Skip to main content
SPARC - Logo
Innovations Inspired by life
Menu

Hamburger

  • Our Company
    • Who we are
    • History
    • Culture
    • Board of Directors
    • Leadership Team
  • OUR RESEARCH
    • Therapeutic focus
    • Delivery Technologies
    • Research Programs
    • R&D Pipeline
  • Our Medicines
    • Xelpros®
    • Elepsia® XR
  • Business Development
    • Strategy
    • Partner with us
  • Accreditations And Approvals
    • Good Laboratory Practice
  • Investors
    • Who we are
    • Financials
    • Annual reports
    • Presentations
    • Chairman's Speech
    • Committees of BOD's
    • Shareholding pattern
    • Announcements & Disclosures
    • Policies & Codes
    • Listing Information
    • Board of Directors
    • FAQ’s
    • Investors Contact
    • Go green
    • IEPF
  • Media
    • Press Releases
    • Presentations
  • Careers
    • Overview
    • Apply Now
  • Contact Us
Our Research » R&D Pipeline

Pipeline Left Menu

  • Our Research
    • Therapeutic Focus
    • Delivery Technologies
    • Research Programs
    • R&D Pipeline

R&D Pipeline

Product Indication Discovery Preclinical Phase 1 Phase 2 Phase 3 Pre-registration Approved / Market
Elepsia® XR (Levetiracetam ER) Epilepsy
Xelpros® (Latanoprost BAK Free) Glaucoma
Taclantis® (PICS) Cancer
SDN – 037 Ocular Pain & Inflammation
PDP - 716 Glaucoma
SCO – 088 CML
SCC - 138 Parkinson’s Disease
SCD – 044 Autoimmune Disorders
SCO - 120 Breast Cancer
ProductElepsia® XR (Levetiracetam ER)
IndicationEpilepsy
Phase in US Pre-registration
ProductXelpros® (Latanoprost BAK Free)
IndicationGlaucoma
Phase in US Approved / Market
ProductTaclantis® (PICS)
IndicationCancer
Phase in US Pre-registration
ProductSDN – 037
IndicationOcular Pain & Inflammation
Phase in US Pre-registration
ProductPDP - 716
IndicationGlaucoma
Phase in US Phase 3
ProductSCO – 088
IndicationCML
Phase in US Phase 2
ProductSCC - 138
IndicationParkinson’s Disease
Phase in US Phase 2
ProductSCD – 044
IndicationAutoimmune Disorders
Phase in US Phase 2
ProductSCO - 120
IndicationBreast Cancer
Phase in US Phase 1

Our Company

  • Who we are
  • history
  • Culture
  • board of directors
  • Leadership team

Our Research

  • Therapeutic focus
  • Delivery Technologies
  • Research Programs
  • R&D Pipeline

Investor Relations

  • Financials
  • Announcements & Disclosures
  • Shareholding pattern
  • Listing Information

Quick Links

Quick Links

  • Business Development
  • Investors
  • Media
  • Careers

Social Connect

  • twitter
  • linkedin

Employee Portal »

Copyright © 2019. Sun Pharma Advanced Research Company Ltd. All rights reserved.
Terms of Use  |   Archival Policy   |   Sitemap
Site Credits